Purpura Fulminans

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA approval · 2023-07-18
EMA Authorised: Ceprotin (human protein C) — Takeda Manufacturing Austria AG
The EMA has authorised Ceprotin (human protein C) for therapeutic use in Purpura Fulminans and Protein C Deficiency.